Health professionals must note the link between women abuse and an increased risk of infection, writes Kate Joyner
The world's second-biggest drug company is cutting its prices for some countries – but not for HIV patients, writes Qudsiya Karrim.
Leading UK and international organisations have written to Britain's largest drug company urging it to pool its patents on HIV medicines.
Protesters disrupted a large HIV/Aids conference in Indonesia on Wednesday to demand access to drugs to treat HIV patients dying from hepatitis C.
The Global Fund to Fight Aids, Malaria and TB, the largest funder of Aids programmes worldwide, has an estimated shortfall of $3-billion to $5-billion